NAMA
TMO icon

Nikko Asset Management Americas’s Thermo Fisher Scientific TMO Stock Holding History

Nikko Asset Management Americas’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-27,207
Closed -$12.4M – 225
2021
Q1 		$12.4M Buy
27,207
+3,282
+14% +$1.57M 0.06% 128
2020
Q4 		$11.1M Sell
23,925
-15,300
-39% -$7.17M 0.06% 125
2020
Q3 		$17.5M Sell
39,225
-3,344
-8% -$1.38M 0.15% 88
2020
Q2 		$15M Sell
42,569
-50,145
-54% -$16.8M 0.2% 71
2020
Q1 		$26.3M Buy
92,714
+19,390
+26% +$6.11M 0.49% 56
2019
Q4 		$23.8M Sell
73,324
-1,657
-2% -$502K 0.38% 65
2019
Q3 		$21.8M Buy
74,981
+9,338
+14% +$2.67M 0.39% 58
2019
Q2 		$19.3M Buy
65,643
+33,054
+101% +$9.1M 0.38% 61
2019
Q1 		$8.92M Buy
+32,589
New +$8.11M 0.24% 71
2018
Q1 		– Sell
-700
Closed -$132K – 247
2017
Q4 		$132K Hold
700
– – ﹤0.01% 203
2017
Q3 		$132K Sell
700
-1,400
-67% -$254K 0.01% 233
2017
Q2 		$366K Hold
2,100
– – 0.02% 202
2017
Q1 		$323K Hold
2,100
– – 0.02% 209
2016
Q4 		$296K Sell
2,100
-100
-5% -$14.7K 0.02% 213
2016
Q3 		$350K Hold
2,200
– – 0.03% 188
2016
Q2 		$319K Hold
2,200
– – 0.03% 190
2016
Q1 		$310K Buy
2,200
+100
+5% +$13.4K 0.04% 183
2015
Q4 		$300K Sell
2,100
-4,400
-68% -$587K 0.03% 165
2015
Q3 		$779K Hold
6,500
– – 0.08% 107
2015
Q2 		$841K Hold
6,500
– – 0.06% 112
2015
Q1 		$881K Sell
6,500
-11,300
-63% -$1.46M 0.07% 111
2014
Q4 		$2.25M Buy
17,800
+6,100
+52% +$742K 0.16% 81
2014
Q3 		$1.43M Buy
11,700
+9,500
+432% +$1.16M 0.09% 96
2014
Q2 		$260K Hold
2,200
– – 0.01% 176
2014
Q1 		$261K Buy
+2,200
New +$262K 0.01% 171

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Nikko Asset Management Americas's TMO Position: Q2 2021 in Review

Nikko Asset Management Americas sold out of Thermo Fisher Scientific (TMO) in Q2 2021, closing a stake of 27,207 shares — an estimated $12.4M sold.

Nikko Asset Management Americas first reported a position in TMO in Q1 2014 and held it in 25 quarters. The position peaked at $26.3M in Q1 2020. 2,074 funds tracked by Wall St. Rank hold TMO as of Q2 2021.

  • Nikko Asset Management Americas reported no remaining Thermo Fisher Scientific position as of Q2 2021 after selling out during the quarter.
  • Nikko Asset Management Americas sold 27,207 Thermo Fisher Scientific shares in Q2 2021, an estimated $12.4M.
  • Nikko Asset Management Americas first reported a position in Thermo Fisher Scientific in Q1 2014 and held it in 25 quarters.
  • Nikko Asset Management Americas's Thermo Fisher Scientific position peaked at $26.3M in Q1 2020.
  • 2,074 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2021.

Based on Nikko Asset Management Americas's 13F filing for Q2 2021, filed 9 Aug 2021.